Vucic, Steve <br/><br/>
Phase 2 randomized placebo controlled double blind study to assess the efficacy and safety of tecfidera in patients with amyotrophic lateral sclerosis (TEALS Study): Study protocol clinical trial (SPIRIT Compliant).  [electronic resource] 

 -  Medicine  Feb 2020 
 - e18904 p.  digital 
<br/><br/> Publication Type: Clinical Trial Protocol; Journal Article 
<br/><br/><label>ISSN: </label>1536-5964 
<br/><br/><label>Standard No.: </label>10.1097/MD.0000000000018904  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Humans<br/>Amyotrophic Lateral Sclerosis--drug therapy<br/>Australia<br/>Dimethyl Fumarate--administration & dosage<br/>Disease Progression<br/>Double-Blind Method<br/>Neuroprotective Agents--administration & dosage<br/>New Zealand<br/>Quality of Life<br/>Randomized Controlled Trials as Topic<br/>Research Design<br/>Clinical Trials, Phase II as Topic<br/>Multicenter Studies as Topic